English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/191224
logo share SHARE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:


Vitamin D and colon cancer

AuthorsBarbáchano, Antonio ; Larriba, María Jesús ; Ferrer-Mayorga, Gemma ; González-Sancho, José Manuel ; Muñoz Terol, Alberto
Colon cancer
Epithelial to mesenchymal transition
Stromal fibroblasts
Vitamin D
Issue Date2018
CitationVitamin D 2(Cap. 99): 837-862 (2018)
AbstractColon cancer is one of the most frequent and lethal neoplasias and the first to be associated with vitamin D deficiency. Many epidemiological studies indicate a protective effect of vitamin D on colon cancer. This is supported by preclinical studies using vitamin D, 1,25(OH)2D3 or analogues in cultured cells and experimental animals. These compounds regulate colon carcinoma cell gene expression, survival, differentiation, proliferation and invasion and inhibit angiogenesis and metastasis during colon cancer progression. Remarkably, in animal and in vitro models vitamin D compounds inhibit the Wnt/β-catenin signaling pathway, whose aberrant activation initiates and maintains colon cancer. Moreover, recent data show that 1,25(OH)2D3 protects against colon cancer acting also on tumor stromal fibroblasts. However, clinical data are scarce and inconclusive, and a definitive answer about the role of vitamin D compounds in the prevention and treatment of colon cancer requires new, large, well-designed clinical trials.
Publisher version (URL)https://doi.org/10.1016/B978-0-12-809963-6.00099-7
Appears in Collections:(IIBM) Libros y partes de libros
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf59,24 kBAdobe PDFThumbnail
Show full item record
Review this work

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.